Anecortave acetate
Anecortave acetate[edit | edit source]
Chemical structure of Anecortave acetate
Synthesis pathway of Anecortave acetate
Anecortave Acetate[edit | edit source]
Anecortave acetate is a synthetic corticosteroid derivative that has been investigated for its potential use in the treatment of ocular conditions, particularly those involving neovascularization. It is a derivative of cortisol and is chemically related to other corticosteroids, but it has been modified to reduce its glucocorticoid activity while retaining its anti-angiogenic properties.
Mechanism of Action[edit | edit source]
Anecortave acetate functions primarily as an anti-angiogenic agent. It inhibits the formation of new blood vessels, a process known as angiogenesis, which is a critical factor in the progression of several ocular diseases. The drug achieves this by interfering with the signaling pathways that promote the proliferation and migration of endothelial cells, which are essential for new blood vessel formation.
Clinical Applications[edit | edit source]
Anecortave acetate has been studied for its potential use in treating age-related macular degeneration (AMD), a leading cause of vision loss in the elderly. In AMD, abnormal blood vessels grow under the retina, leading to vision impairment. By inhibiting angiogenesis, anecortave acetate aims to prevent the progression of this condition.
Administration[edit | edit source]
The drug is typically administered as a periocular injection, which involves delivering the medication to the area surrounding the eye. This method allows for localized treatment, minimizing systemic exposure and potential side effects associated with corticosteroids.
Research and Development[edit | edit source]
While anecortave acetate showed promise in early clinical trials, subsequent studies yielded mixed results regarding its efficacy compared to other treatments, such as anti-VEGF therapies. As a result, its development has been limited, and it is not widely used in clinical practice.
Related Pages[edit | edit source]
This article is a ophthalmology stub. You can help WikiMD by expanding it!
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
